Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Monofer Phase I in Japanese IDA
NCT03013439Phase 1Completed
- Sponsor
- Pharmacosmos
- Start
- Jan 2017
- Primary completion
- Jun 2017
- Modality
- Inorganic Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of ferric derisomaltose in iron deficiency anemia (IDA) (4 cohorts), sponsored by Pharmacosmos. Primary endpoint: Proportion of adverse events at 1 week. Started Jan 2017; status: completed.
02
Drugs
ferric derisomaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT03013439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03013439.